In accordance with these data, another study demonstrated that increased expression of the CCR6 ligand CCL20 in colon tumor tissue was associated with worse overall survival of CRC patients under neoadjuvant chemotherapy [27]. The gene discussed is CCR6; the disease is colonic neoplasm.